Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Epic Sciences Raises $43M in First Close of Series F Financing to Advance Comprehensive Profiling for Metastatic Cancer Patients
Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $43 […]
Florence Raises $35 Million (£28.5m) to Revolutionise Social Care Staffing
Florence, the UK-based tech innovator for social care, announced it has raised $35 million (£28.5m) […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury
Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the […]
Tobias Hauser Joins Limbic to Help Close UK Demand-supply Gap of Psychological Therapy
Tobias Hauser, joins Limbic as its Head of Computational Psychiatry. Hauser has worked at the […]
seqWell and Element Biosciences Partner to Demonstrate Sequencing Performance of Multiplexed plexWell Technology With the AVITI System
seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today […]
GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on […]
Jubilant HollisterStier LLC Enters Into Cooperative Agreement of $149.6 Mn With US Government to Expand Critical Vaccine Manufacturing Capacity
Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of […]
Tetra Bio-Pharma Appoints Chief Financial Officer
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more